Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PULSAR Combined With Immunotherapy and Chemotherapy in Cholangiocarcinoma
NCT07291947Phase 2Recruiting
- Start
- Nov 2025
- Primary completion
- Sep 2026
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in cholangiocarcinoma (CCA). Started Nov 2025; status: recruiting.
02
Drugs
QL1706
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT07291947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07291947.